Cambridge, MACIK 19175294 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
8 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Kymera Therapeutics Inc | 4.66M | $362.58M | 41.9% | −236.6K | Reduced |
| 2 | Dyne Therapeutics Inc | 9.13M | $178.59M | 20.6% | 0 | Held |
| 3 | Sionna Therapeutics Inc | 3.00M | $123.24M | 14.2% | −619.9K | Reduced |
| 4 |
| 1.51M |
| $120.22M |
| 13.9% |
| −628.7K |
| Reduced |
| 5 | Day One Biopharmaceuticals I | 6.41M | $59.77M | 6.9% | −17.7K | Reduced |
| 6 | Korro Bio Inc | 1.14M | $9.11M | 1.1% | 0 | Held |
| 7 | Q32 Bio Inc | 2.09M | $6.95M | 0.8% | 0 | Held |
| 8 | Generation Bio Co | 827.9K | $4.70M | 0.5% | +827.9K | New |